Growing Market Applications, Centerline Biomedical Granted FDA 510(k) Clearance for IOPS® with New, Expanded Indication for Use
/
DateMar 11 2025
CLEVELAND–(BUSINESS WIRE)–Centerline Biomedical, Inc. (“Centerline”), an innovative leader in cardiovascular navigation and visualization systems, announced that the company has received US Food and Drug Administration... Read More →

















